Bristol-Myers Squibb (BMY) Offers Low Volatility and High Yield
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowBristol-Myers Squibb Company (BMY) ranks 5th among the best defensive stocks and is recognized for low volatility and high yield. The stock features a beta that is approximately 73% less volatile than the S&P 500. Recent updates include a quarterly dividend of $0.63 per share and a cash payout ratio of about 35%. In the recent quarter, growth products like Camzyos and Sotyktu saw a 10% increase, which strengthens BMY's long-term revenue outlook despite some earnings challenges.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb is a major pharmaceutical company focused on oncology and immunology.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier BMY news
BMY stock page and all news βGet the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
